Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells

Soichi Hirai, Tadaaki Yamada, Yuki Katayama, Masaki Ishida, Hayato Kawachi, Yohei Matsui, Ryota Nakamura, Kenji Morimoto, Mano Horinaka, Toshiyuki Sakai, Yoshitaka Sekido, Shinsaku Tokuda, Koichi Takayama

Mol Cancer Ther (2024) 23 (2): 212–222.

https://doi.org/10.1158/1535-7163.MCT-23-0138

Published: 01 February 2024

View article titled, Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells

Includes: Supplementary data

Journal Articles

The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA

Yohei Sugimoto, Yoshiki Katsumi, Tomoko Iehara, Daisuke Kaneda, Chihiro Tomoyasu, Kazutaka Ouchi, Hideki Yoshida, Mitsuru Miyachi, Shigeki Yagyu, Ken Kikuchi, Kunihiko Tsuchiya, Yasumichi Kuwahara, Toshiyuki Sakai, Hajime Hosoi

Mol Cancer Ther (2020) 19 (10): 1992–2000.

https://doi.org/10.1158/1535-7163.MCT-20-0243

Published: 02 October 2020

View article titled, The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA

Includes: Supplementary data

Journal Articles

A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells

Seijiro Toriyama, Mano Horinaka, Shusuke Yasuda, Tomoyuki Taniguchi, Yuichi Aono, Toshiya Takamura, Yukako Morioka, Tsuneharu Miki, Osamu Ukimura, Toshiyuki Sakai

Mol Cancer Ther (2016) 15 (9): 2066–2075.

https://doi.org/10.1158/1535-7163.MCT-16-0010

Published: 01 September 2016

View article titled, A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells

Includes: Supplementary data

Journal Articles

Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules

Hiroya Taniguchi, Mano Horinaka, Tatsushi Yoshida, Kimihiro Yano, Ahmed E. Goda, Shusuke Yasuda, Miki Wakada, Toshiyuki Sakai

Mol Cancer Ther (2012) 11 (10): 2294–2300.

https://doi.org/10.1158/1535-7163.MCT-12-0031

Published: 09 October 2012

View article titled, Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules

Includes: Supplementary data

Journal Articles

ZD1839 induces p15^INK4b and causes G₁ arrest by inhibiting the mitogen-activated protein kinase/extracellular signal–regulated kinase pathway

Makoto Koyama, Youichirou Matsuzaki, Shingo Yogosawa, Toshiaki Hitomi, Mayumi Kawanaka, Toshiyuki Sakai

Mol Cancer Ther (2007) 6 (5): 1579–1587.

https://doi.org/10.1158/1535-7163.MCT-06-0814

Published: 18 May 2007

View article titled, ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal–regulated kinase pathway

Journal Articles

Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1

Stavroula Baritaki, Sara Huerta-Yepez, Toshiyuki Sakai, Demetrios A. Spandidos, Benjamin Bonavida

Mol Cancer Ther (2007) 6 (4): 1387–1399.

https://doi.org/10.1158/1535-7163.MCT-06-0521

Published: 12 April 2007

View article titled, Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1

Journal Articles

15-Deoxy-Δ^12,14-prostaglandin J₂ induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis

Susumu Nakata, Tatsushi Yoshida, Takumi Shiraishi, Mano Horinaka, Junji Kouhara, Miki Wakada, Toshiyuki Sakai

Mol Cancer Ther (2006) 5 (7): 1827–1835.

https://doi.org/10.1158/1535-7163.MCT-06-0023

Published: 04 August 2006

View article titled, 15-Deoxy-Δ12,14-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis

Journal Articles

The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand

Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Toshiyuki Sakai

Mol Cancer Ther (2006) 5 (4): 945–951.

https://doi.org/10.1158/1535-7163.MCT-05-0431

Published: 28 April 2006

View article titled, The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand

NARROW

Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells

The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA

A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells

Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules

ZD1839 induces p15^INK4b and causes G₁ arrest by inhibiting the mitogen-activated protein kinase/extracellular signal–regulated kinase pathway

Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1

15-Deoxy-Δ^12,14-prostaglandin J₂ induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis

The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only